CAPITALIZING ON THE EMERGENCE OF PSYCHEDELIC MEDICINE FOR MENTAL HEALTH CONDITIONS.
Champignon Brands Inc. ("Champignon") is a Canadian based company dedicated to the distribution of artisanal, medicinal mushrooms and associated CPGs. The Champignon team believes that we can enhance the health and wellness of millions of consumers through the distribution of our premium, mushroom-infused suite of products.
Champignon is pursuing the development and commercialization of rapid onset treatments capable of improving health outcomes, such as depression and post-traumatic stress disorder (PTSD), as well as substance and alcohol use disorders. Champignon continues to be inspired by sustainability, as its medicinal mushroom-infused SKUs are organic, non- GMO and vegan certified.
Together, the Champignon Brands platform targets key segments in the industry that complement each other as the industry accelerates. Ketamine, psilocybin and MDMA have all been Fast Tracked by the FDA and Health Canada with respect to R&D in DPS.
Champignon Brands Inc. is a publicly traded company listed on the OTCQB under the ticker symbol SHRMF. This is not investment advice. Please view the disclaimer found on this website.